Literature DB >> 33520839

Impact of glycemic control over cardiac autonomic neuropathy.

Meghanad Meher1, Jayanta Kumar Panda2.   

Abstract

PURPOSE: Cardiovascular autonomic neuropathy (CAN) is one of the most common and serious complications associated with diabetes and is defined as the impairment of the autonomic control of the cardiovascular system, whose prevalence in Indian population has been reported to be > 50%. The risk factors associated with CAN include hyperglycemia, duration of diabetes, hypertension, dyslipidemia, and obesity. This study was conducted to examine the association of CAN with its determinants among diabetics.
METHODS: Socio-demographic characteristics were noted alongwith performance of biochemical analyses of blood samples according to standard hospital pathology laboratory protocols. Clinical assessment of CAN comprised a of 5 indexes, including 3 heart rate variability parameters (resting tachycardia, Qtc interval > 440 msec, exercise intolerance) and 2 blood pressure parameters (orthostatic hypotension, abnormal hand gripping test).
RESULTS: The odds of CAN increased with poor glycemic control (FBS ≥ 126 mg/dL (OR = 1.17 (1.02-10.68); 2 hr PPBS ≥ 200 mg/dL (OR 1.63 (1.26-8.82) and HbA1c ≥ 6.5% (OR = 10.68 (1.54-208.02). Significant difference was also found in relation to duration of diabetes, weight and body mass index of the participants with various grades of CAN.
CONCLUSIONS: CAN is associated strongly with poor glycemic control. Obesity seems to be involved in the impairments of the cardiac autonomic function and this factor must therefore be taken into account in future studies when interpreting the results. Body mass control and glycemic control could provide an important approach to reducing CAN. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Cardiovascular Diseases; Diabetes; Diabetic Autonomic Neuropathy; Diabetic Complications

Year:  2020        PMID: 33520839      PMCID: PMC7843741          DOI: 10.1007/s40200-020-00653-7

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  26 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

Review 2.  Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

Authors:  Akif Serhat Balcıoğlu; Haldun Müderrisoğlu
Journal:  World J Diabetes       Date:  2015-02-15

3.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

4.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.

Authors:  Vincenza Spallone; Dan Ziegler; Roy Freeman; Luciano Bernardi; Simona Frontoni; Rodica Pop-Busui; Martin Stevens; Peter Kempler; Jannik Hilsted; Solomon Tesfaye; Phillip Low; Paul Valensi
Journal:  Diabetes Metab Res Rev       Date:  2011-10       Impact factor: 4.876

Review 5.  Cardiac autonomic neuropathy in patients with diabetes mellitus.

Authors:  Gerasimos Dimitropoulos; Abd A Tahrani; Martin J Stevens
Journal:  World J Diabetes       Date:  2014-02-15

6.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.

Authors:  K Ogurtsova; J D da Rocha Fernandes; Y Huang; U Linnenkamp; L Guariguata; N H Cho; D Cavan; J E Shaw; L E Makaroff
Journal:  Diabetes Res Clin Pract       Date:  2017-03-31       Impact factor: 5.602

7.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

8.  Diabetes and cardiovascular disease. The Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

Review 9.  Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

Authors:  Solomon Tesfaye; Andrew J M Boulton; Peter J Dyck; Roy Freeman; Michael Horowitz; Peter Kempler; Giuseppe Lauria; Rayaz A Malik; Vincenza Spallone; Aaron Vinik; Luciano Bernardi; Paul Valensi
Journal:  Diabetes Care       Date:  2010-10       Impact factor: 19.112

10.  Assessment of the cardiac autonomic neuropathy among the known diabetics and age-matched controls using noninvasive cardiovascular reflex tests in a South-Indian population: A case-control study.

Authors:  Pradeep Sukla; Saurabh RamBihariLal Shrivastava; Prateek Saurabh Shrivastava; Nambaru Lakshmana Rao
Journal:  Avicenna J Med       Date:  2016 Jul-Sep
View more
  1 in total

1.  Exercise as a Therapeutic Intervention in Gestational Diabetes Mellitus.

Authors:  Konstantina Dipla; Andreas Zafeiridis; Gesthimani Mintziori; Afroditi K Boutou; Dimitrios G Goulis; Anthony C Hackney
Journal:  Endocrines       Date:  2021-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.